Analyst Price Target is $0.90
▲ +2.85% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for MedEquities Realty Trust in the last 3 months. The average price target is $0.90, with a high forecast of $0.90 and a low forecast of $0.90. The average price target represents a 2.85% upside from the last price of $0.88.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in MedEquities Realty Trust. This Buy consensus rating has held steady for over two years.
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.